SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-23-024137
Filing Date
2023-03-29
Accepted
2023-03-29 17:01:24
Documents
6
Effectiveness Date
2023-03-29

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea176021-s8_biomxinc.htm S-8 37240
2 OPINION OF SULLIVAN & WORCESTER LLP ea176021ex5-1_biomxinc.htm EX-5.1 7559
3 CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER ea176021ex23-1_biomxinc.htm EX-23.1 1941
4 FILING FEE TABLE ea176021ex-fee_biomxinc.htm EX-FILING FEES 16319
5 GRAPHIC ex5-1_001.jpg GRAPHIC 6125
6 GRAPHIC ex5-1_002.jpg GRAPHIC 1682
  Complete submission text file 0001213900-23-024137.txt   75204
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270947 | Film No.: 23776002
SIC: 2836 Biological Products, (No Diagnostic Substances)